Efficacy And Safety Of Open-Label Caplacizumab In Patients With Exacerbations Of Acquired Thrombotic Thrombocytopenic Purpura During The Phase Iii Hercules Study

HAEMATOLOGICA(2018)

Cited 44|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined